Abstract
Lung cancer remains the leading cause of cancer mortality globally. Low survival rate is related with diagnosis in advanced stages. Treatment of choice for early stages is surgery. Delaying surgical treatment in larger tumor sizes or suspicious N1 lymph nodes can result in upstaging and consequently poorer prognosis. COVID19 interfered with elective medical care, reducing number of patients referred for thoracic surgeons. We wanted to analyze the COVID19 pandemic impact in the number of patients that had lung cancer resection.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
